|
J Biol Chem, Vol. 274, Issue 32, 22231-22237, August 6, 1999
ATP Regulation of Type 1 Inositol 1,4,5-Trisphosphate Receptor
Channel Gating by Allosteric Tuning of Ca2+ Activation*
Don-On Daniel
Mak ,
Sean
McBride , and
J. Kevin
Foskett §¶
From the Department of Physiology and
§ Institute for Human Gene Therapy, University of
Pennsylvania, Philadelphia, Pennsylvania 19104-6100
 |
ABSTRACT |
Inositol 1,4,5-trisphosphate
(InsP3) mobilizes intracellular Ca2+ by
binding to its receptor (InsP3R), an endoplasmic
reticulum-localized Ca2+ release channel. Patch clamp
electrophysiology of Xenopus oocyte nuclei was used to
study the effects of cytoplasmic ATP concentration on the cytoplasmic
Ca2+ ([Ca2+]i) dependence of single
type 1 InsP3R channels in native endoplasmic reticulum
membrane. Cytoplasmic ATP free-acid ([ATP]i), but not the
MgATP complex, activated gating of the InsP3-liganded InsP3R, by stabilizing open channel state(s) and
destabilizing the closed state(s). Activation was associated with a
reduction of the half-maximal activating [Ca2+]i
from 500 ± 50 nM in 0 [ATP]i to 29 ± 4 nM in 9.5 mM [ATP]i, with apparent
ATP affinity = 0.27 ± 0.04 mM, similar to in
vivo concentrations. In contrast, ATP was without effect on
maximum open probability or the Hill coefficient for Ca2+
activation. Thus, ATP enhances gating of the InsP3R by
allosteric regulation of the Ca2+ sensitivity of the
Ca2+ activation sites of the channel. By regulating the
Ca2+-induced Ca2+ release properties of the
InsP3R, ATP may play an important role in shaping
cytoplasmic Ca2+ signals, possibly linking cell metabolic
state to important Ca2+-dependent processes.
 |
INTRODUCTION |
Modulation of free cytoplasmic Ca2+ concentration
([Ca2+]i) is a ubiquitous cellular signaling
system. In many cell types, binding of ligands to plasma membrane
receptors activates the hydrolysis of phosphatidylinositol
4,5-bisphosphate by membrane-bound phospholipase C, generating inositol
1,4,5-trisphosphate
(InsP3).1
InsP3 causes the release of Ca2+ from the
endoplasmic reticulum (ER) by binding to its receptor (InsP3R), which itself is a Ca2+ channel
(1-3). Complex control of Ca2+ release through the
InsP3R by various intracellular factors, including
cooperative activation by InsP3 (4-8) and biphasic feedback from the permeant Ca2+ ion (6, 8-11) generates
intricate [Ca2+]i signals that can be manifested
temporally as repetitive spikes or oscillations, with frequencies often
tuned to the level of stimulation, and spatially as propagating waves
or highly localized events (2, 12, 14) and display properties of
"adaptation" and "quantal release," which are poorly understood
(15). Several types of InsP3R as products of different
genes with alternatively spliced isoforms have been identified and
sequenced (16, 17). The InsP3Rs have about 2700 amino acid
residues in InsP3 binding, regulatory (modulatory) and
transmembrane channel domains (16-18). The sequences of the regulatory
domains of all InsP3R isoforms include putative ATP-binding
site(s) (17). ATP was shown to bind to the InsP3R (19) and
regulate InsP3R-mediated Ca2+ release (20-24),
although the detailed mechanisms of this regulation remain unclear.
Several studies have demonstrated that mitochondria and the ER are in
close physical and functional proximity in many cell types, including
neurons (24-27). [Ca2+]i signals generated by
InsP3R-mediated Ca2+ release from the ER appear
to be rapidly and efficiently transmitted to mitochondria (28-30),
acutely affecting mitochondrial functions (31-33), including ATP
synthesis (34). It is unknown, however, whether the communication
between these two organelles is reciprocal. ATP release from
mitochondria, globally into the cytoplasm and locally into the vicinity
of the InsP3R channels that are in close apposition, may
provide a signaling pathway for communication from the mitochondria
back to the ER. Thus, regulation of the InsP3R by ATP could
have considerable significance for intracellular signaling,
particularly if the channel is sensitive to ATP levels in normal
physiological as well as pathological conditions, including ischemia.
Most previous studies of ATP regulation of the InsP3R have
been limited to indirect measurements, i.e. Ca2+
fluxes or concentrations, to infer InsP3R channel activity,
because the intracellular location of the Ca2+ release
channel has limited its accessibility to electrophysiological approaches. Furthermore, only a limited range of
[Ca2+]i was examined in previous studies, despite
the fact that the InsP3R is intricately regulated by
[Ca2+]i (6, 8-11) and that the primary known
regulator of the channel, InsP3, mediates its effects by
modulating the [Ca2+]i dependence of channel
gating (8). Therefore, in the present study, we have systematically
investigated the effects of cytoplasmic ATP concentration on the
[Ca2+]i response of single InsP3R
channels. We applied the patch clamp technique to isolated
Xenopus oocyte nuclei (35-37) to study the single channel
activities of the type 1 InsP3R (InsP3R-1), the
major brain isoform (38, 39), in its native ER membrane environment
under rigorously defined conditions on both the cytoplasmic and luminal
sides of the channel. Our results demonstrate that cytoplasmic ATP free
acid, but not cytoplasmic MgATP complex, activates the gating of the
InsP3R primarily by allosteric regulation of the
[Ca2+]i sensitivity of the Ca2+
activation sites of the channel. By regulating the
Ca2+-induced Ca2+ release properties of the
InsP3R, ATP may play an important role in shaping the
extent and duration of [Ca2+]i signals, possibly
linking cell metabolic state to important
Ca2+-dependent process including synaptic plasticity.
 |
EXPERIMENTAL PROCEDURES |
Patch Clamping the Oocyte Nucleus--
Patch clamp experiments
were performed as described in Refs. 8, 35, 36, and 40. Briefly, stage
V or VI oocytes were opened mechanically just prior to use. The nucleus
was separated from the cytoplasm and transferred to a dish on the stage
of a microscope for patch-clamping. The oocyte expresses only a single InsP3R isoform (type 1) and lacks other (e.g.
ryanodine receptor) Ca2+ release channels (41). Experiments
were done in "on-nucleus" configuration, with the solution in the
perinuclear lumen between the outer and inner nuclear membranes in
apparent equilibrium with the bath solution (35) and with the
cytoplasmic aspect of the InsP3R channel facing into the
patch pipette. Following standard conventions, the applied potential is
that of the pipette electrode minus the reference bath electrode
(positive current flows from pipette outward). Experiments were
performed at room temperature with the pipette electrode at +20 mV
relative to the reference bath electrode.
Data Acquisition and Analysis--
Single channel currents were
amplified with an Axopatch-1D amplifier (Axon Instruments, Foster City,
CA) with antialiasing filtering at 1 kHz, transferred to a Power
Macintosh 8100 via an ITC-16 interface (Instrutech Corp., Great Lake,
NY), digitized at 5 kHz, and written directly onto the hard disc by
Pulse+PulseFit software (HEKA Elektronik, Lambrecht, Germany). Data
were analyzed to identify channel opening and closing events and
evaluate channel open probabilities using MacTac 3 (Bruxton, Seattle,
WA). Each data point shown is the mean of results from at least four
separate patch clamp experiments performed under the same conditions.
Error bars indicate the S.E. Theoretical curves were fitted to
experimental data using Igor Pro 3 (WaveMetrics, Lake Oswego, OR).
Solutions for Patch Clamp Experiments--
All patch clamp
experiments were performed with solutions containing 140 mM
KCl and 10 mM HEPES with pH adjusted to 7.1 using KOH.
Since the luminal [Ca2+] or [ATP] have no systematic
effects on the open probability response of the InsP3R (8),
a bath solution containing no ATP and 250 nM free
Ca2+ was used in all experiments. Pipette solutions
contained various concentrations of nucleotides (sodium salts of ATP,
ADP, AMP, GTP, and UTP and adenosine, from Sigma) as specified. Because of chelation of Mg2+ by ATP, the actual free
[Mg2+] and free [ATP] in the solutions containing
Mg2+ and ATP were calculated by the Maxchelator software
(C. Patton, Stanford University, Stanford, CA). By using K+
as the current carrier and appropriate quantities of the high affinity
Ca2+ chelator, BAPTA (100-500 µM; Molecular
Probes, Inc., Eugene, OR), the low affinity Ca2+ chelator,
5,5'-dibromo-BAPTA (100-350 µM; Molecular Probes), or
just ATP (0 or 0.5 mM) to buffer [Ca2+] in
the experimental solutions, [Ca2+] was tightly controlled
in our experiments. Total Ca2+ content (60-370
µM) in the solutions was determined by induction-coupled plasma mass spectrometry (Mayo Medical Laboratory, Rochester, MN). Free
[Ca2+] was calculated using the Maxchelator software.
Pipette solutions contained 10 µM InsP3
(Molecular Probes).
 |
RESULTS |
Activation of Channel Gating by ATP--
To examine the effects of
ATP on the permeation and gating properties of the InsP3R,
we included 10 µM InsP3, 250 nM
free Ca2+, and 0.5 mM free ATP in the pipette
solution. Under these conditions, the endogenous Xenopus
type 1 InsP3R channel exhibited channel conductance
properties and kinetics similar to those observed previously under
similar conditions (8, 40). The channels gated with a moderately high
open probability (Po) of ~0.5 (Fig. 1A). In similar experiments
employing pipette solutions that lacked ATP, the InsP3R
channel Po was significantly lower (~0.2) in
either the absence or presence of 3 mM Mg2+
(Fig. 1, B and C). To determine whether the ATP
activation of the channel Po was mediated by
MgATP, which could suggest a role for ATP hydrolyisis or
phosphorylation, similar experiments were undertaken with 3 mM total Mg2+ and 0.5 mM total ATP
in the pipette. Under these conditions, [MgATP] is approximately 0.5 mM, and the free Mg2+ concentration
([Mg2+]i) and the cytoplasmic free ATP
concentration ([ATP]i) were calculated to be 2.5 and 0.012 mM, respectively. Nevertheless, Po
remained low (Fig. 1D). The low Po in
the presence of MgATP (Fig. 1) was solely caused by ATP complexation by
Mg2+, since it was fully reversed by adding more ATP to the
pipette solution to restore [ATP]i (Fig. 1E).
Thus, MgATP has no effect, stimulatory or inhibitory, on
InsP3R activity. We previously demonstrated that the
Po of the Xenopus type 1 InsP3R is independent of [Mg2+]i up
to 9.5 mM (40). Taken together, these results suggest that
ATP free acid (ATP3 or ATP4 ) was the
relevant ionic species and that ATP hydrolysis was not involved in the
stimulation of InsP3R channel gating.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
Typical current traces of InsP3R
channels in outer nuclear membrane at [Ca2+]i = 250 ± 20 nM under various [ATP]i and
[Mg2+]i. The arrows indicate
closed channel current levels. A, [ATP]i = 0.5 mM; [Mg2+]i = 0 mM.
B, [ATP]i = 0 mM;
[Mg2+]i = 0 mM. C,
[ATP]i = 0 mM; [Mg2+]i = 3.0 mM. D, [ATP]i = 12 µM; [Mg2+]i = 2.5 mM
(0.5 mM total ATP; 3 mM total
Mg2+). Reduction of InsP3R channel conductance
in the presence of Mg2+ (C and D) is
caused by permeant ion block of the channel by the divalent cation
(40). E, [ATP]i = 1.9 mM;
[Mg2+]i = 113 µM (4.8 mM total ATP; 3 mM total
Mg2+).
|
|
Effects of ATP on the [Ca2+]i Dependence
of InsP3R Gating--
InsP3 activates the
InsP3R by modulating the sensitivity of the channel to
[Ca2+]i (8). To determine the mechanism of ATP
activation of the InsP3R channel gating, we investigated in
detail the effects of ATP on the channel kinetics of the
InsP3R over a wide range of [Ca2+]i.
A systematic series of patch clamp experiments were performed using
pipette solutions containing various [Ca2+]i with
0.5 mM ATP alone, 3 mM Mg2+ alone,
0.5 mM ATP, and 3 mM Mg2+
(calculated [ATP]i = 0.012 mM; calculated
[Mg2+]i = 2.5 mM) or no ATP or
Mg2+. To avoid possible effects of Ca2+ on
InsP3 binding, a functionally saturating InsP3
concentration of 10 µM was used (8). The
[Ca2+]i sensitivity of the InsP3R in
the absence of cytoplasmic free ATP was biphasic (Fig.
2) and could be well fitted with a biphasic Hill equation similar to the following one previously derived
for the InsP3R in the presence of 0.5 mM
cytoplasmic free ATP (8).
|
(Eq. 1)
|
Similar results were obtained independent of the presence or
absence of either Mg2+ or MgATP in the pipette solutions.
This result indicates that the InsP3R can achieve a maximum
open probability Pmax of 0.79 in the absence of
cytoplasmic free ATP, a level of activity very similar to the
Pmax of 0.81 found in the presence of 0.5 mM cytoplasmic free ATP (8). Thus, ATP does not activate
the channel by increasing Pmax. The Hill
coefficient for Ca2+ activation Hact
was 2.4 ± 0.6 in the absence of free ATP, similar to
Hact = 1.9 ± 0.3 in the presence of 0.5 mM free ATP. This result suggests that Ca2+
probably activates the InsP3R via the same cooperative
process in either the presence or absence of cytoplasmic free ATP.
Thus, ATP does not activate the channel by modulating
Hact. The observed activation of the
InsP3R by cytoplasmic free ATP (Fig. 1) was associated with
a reduction of the half-maximal activating
[Ca2+]i (Kact) from
500 ± 50 nM in the absence of free ATP to 190 ± 20 nM in the presence of 0.5 mM free ATP. Thus,
ATP activates the channel by sensitizing it to Ca2+. ATP
therefore enhances Ca2+-induced Ca2+ release
(CICR) by the InsP3R.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
[Ca2+]i dependence of
the InsP3R channel Po in the
presence of low (~0 mM) [ATP]i.
Open triangles represent data with
[ATP]i = 0 mM and [Mg2+]i = 0 mM. Open squares represent data
with [ATP]i = 0 mM and
[Mg2+]i = 3.0 mM. Open
circles represent data with [ATP]i = 12 µM and [Mg2+]i = 2.5 mM
(0.5 mM total ATP; 3 mM total
Mg2+). The solid curve is the
biphasic Hill equation fit using Equation 1. For comparison,
Po data of the InsP3R in the
presence of 0.5 mM [ATP]i (small
filled circles) and the corresponding biphasic
Hill equation fit (dotted curve; published in
Ref. 8) are also shown.
|
|
Because InsP3 activates channel gating by modifying the
[Ca2+]i inhibition phase of the channel
[Ca2+]i dependence (8), we were also interested
in examining the effects of ATP on this aspect of the response.
However, investigations of InsP3R channel activity in the
absence of free ATP at [Ca2+]i which inhibit
channel gating (>20 µM; Ref. 8) were not possible
because of the unavailability of a Ca2+ chelator with the
appropriate Ca2+ affinity. In our previous experiments that
examined the effects of high [Ca2+]i on
InsP3R channel gating (8), ATP was used as the Ca2+ chelator for buffering [Ca2+]i
at high [Ca2+]i. The data we were able to obtain
in the absence of ATP in the present study indicated that
Po began to decrease as [Ca2+]i was increased beyond 10 µM,
but the inhibitory half-maximal [Ca2+]i,
Kinh, or Hill coefficient,
Hinh, could not be determined accurately (Fig.
2).
Effects of ATP on InsP3R Channel
Kinetics--
Analysis of the mean open and closed durations of the
InsP3R revealed that the mean open duration
( o) in the absence of free ATP lay within a narrow range
between 5 and 15 ms over a wide range of [Ca2+]i
(1-10 µM). At both very low (<400 nM) or
very high (>10 µM) [Ca2+]i,
o was shorter (~3 ms) (Fig.
3). In contrast, the mean closed duration
( c) in the absence of free ATP decreased about 2 orders
of magnitude, from 200 to 3 ms, as [Ca2+]i was
increased from 200 nM to 1 µM.
c remained low between 1 and 10 µM
[Ca2+]i (Fig. 4).
These same basic kinetics were observed in all experiments conducted in
the absence of cytoplasmic free ATP, regardless of the presence or
absence of free Mg2+ or MgATP complex. Similar
[Ca2+]i dependences of o and
c (Figs. 3 and 4) were also observed in the presence of
0.5 mM free ATP (8). An examination of the differences in
the [Ca2+]i dependences of o and
c in either the presence and absence of cytoplasmic free
ATP reveals that the mechanism whereby free ATP enhances channel
activity is by stabilization of the open channel state(s) and
destabilization of the closed channel state(s) in the low
[Ca2+]i regime (30-500 nM). Our more
limited data indicate that free ATP may also stabilize the open channel
state(s) at very high [Ca2+]i (>15
µM).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
[Ca2+]i dependence of
the mean open durations of the InsP3R channels in the
absence of free cytoplasmic ATP (A) and in the
presence of 0.5 mM free ATP (B). The
symbols used are the same as those in Fig. 2.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
[Ca2+]i dependence of
the mean closed durations of the InsP3R channels in the
absence of free cytoplasmic ATP (A) and in the
presence of 0.5 mM free ATP (B). The
symbols used are the same as those in Fig. 2.
|
|
ATP Concentration Dependence of Ca2+ Activation of
InsP3R Gating--
We undertook a systematic study of the
activation of the InsP3R by [Ca2+]i
over a wide range of free [ATP]i. In the presence of 10 µM InsP3, the activating Hill equation
(Equation 2) agreed well the experimental data for [ATP]i of
4.8 and 9.5 mM, with no significant effects of
[ATP]i on Hact or
Pmax (Fig. 5).
|
(Eq. 2)
|
[ATP]i decreased Kact of the
InsP3R by over an order of magnitude, from 500 ± 50 nM in 0 mM [ATP]i to 29 ± 4 nM in 9.5 mM [ATP]i. The effects of
[ATP]i on Kact of the
InsP3R were analyzed by fitting the data with a modified
Michaelis-Menten equation (Fig.
6).
|
(Eq. 3)
|
A modification to the standard Michaelis-Menten equation was
necessary because ATP alone is insufficient to activate the channel in
absence of InsP3, and therefore the activating half-maximal [Ca2+]i (Kact) should not
approach 0 even in presence of saturating concentrations of ATP. The
results indicate that the range over which Kact
of the InsP3R varies in response to [ATP]i, Kr = 480 ± 20 nM; the minimum
Kact under saturating [ATP]i, Kmin = 17 ± 3 nM; and the
functional dissociation coefficient for cytoplasmic free ATP activation
of the InsP3R, KATP = 0.27 ± 0.04 mM. The good fit of this equation to the data suggests that ATP stimulation of channel activity is not cooperative, requiring binding of only one ATP molecule to the InsP3R tetramer to
stimulate it.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of [ATP]i on activation of
the InsP3R by [Ca2+]i. The
different symbols plotted correspond to various
[ATP]i used, as tabulated in the graph (in mM).
The curves are Hill equation fits for the corresponding experimental
data: for 0 mM [ATP]i,
Hact = 2.4, Kact = 500 nM, and Pmax = 0.79; for 0.5 mM [ATP]i, Hact = 1.9, Kact = 190 nM, and
Pmax = 0.81; for 4.8 mM
[ATP]i, Hact = 2.3, Kact = 45 nM, and
Pmax = 0.71; for 9.5 mM
[ATP]i, Hact = 2.4, Kact = 29 nM, and
Pmax = 0.82. For 0.3 mM
[ATP]i, assuming that Hact = 2 and
Pmax = 0.8, Hill equation fitting gives
Kact = 230 nM.
|
|

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of [ATP]i on the activating
half-maximal [Ca2+]i
(Kact) of the InsP3R. The
curve is the theoretical fit based on the modified
Michaelis-Menten equation (Equation 3).
|
|
Nucleotide Specificity--
To determine the nucleotide
specificity of the stimulatory effects we observed for free ATP, we
also investigated the effects of adenosine, AMP, ADP, GTP, and UTP.
Each nucleotide was present as 0.5 mM free nucleotide in
the absence of Mg2+. The [Ca2+]i was
fixed at 220 ± 15 nM, because the
Po is very sensitive to activation by free ATP
at this [Ca2+]i (Fig. 2). Using the channel
Po (0.14) in the absence of any nucleotide as
the reference, the relative Po of the channel was determined in the presence of the various nucleotide species (Fig.
7). Similar to the MgATP complex, free
UTP, ADP, and adenosine had no effects on the Po
of the InsP3R (p > 0.05). In contrast, free ATP, AMP, and GTP each activated the InsP3R
(p < 0.05). Free ATP had the greatest effect, more
than tripling the Po, whereas both free AMP and
GTP doubled the channel Po.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
Relative open probabilities of
InsP3R in the presence of 0.5 mM free
cytoplasmic nucleotides. [Ca2+]i = 220 ± 15 nM. Po = 0.14 in the absence
of any nucleotide. Total [Mg2+] is 3 mM for
data labeled MgATP and 0 mM for the rest.
|
|
 |
DISCUSSION |
We previously described the detailed permeation and gating
properties of the Xenopus type 1 InsP3R channel
by patch clamp studies of isolated oocyte nuclei (8, 35, 36, 40). Under optimal conditions, gating of the channel is robust, with maximum open
probability of ~80% over a wide range of
[Ca2+]i (8). Importantly, the gating of the
channel is regulated by both InsP3 as well as by
[Ca2+]i. The regulation of the
InsP3-liganded channel activity by
[Ca2+]i is biphasic, with half-maximal activation
at 210 nM and half-maximal inhibition at 45 µM in 10 µM InsP3.
InsP3 binds noncooperatively to a high affinity site
(KD ~ 50 nM) on each monomer of the
channel tetramer. Binding of InsP3 to the channel has the
sole effect of decreasing the Ca2+ affinity of the
Ca2+ inhibition site on each monomer, in a process which
has high cooperativity (Hill coefficient of 4) (8). When cytoplasmic InsP3 concentration ([InsP3]i) is
low, under conditions of no or weak stimulation, the channel is
inhibited by relatively low [Ca2+]i, whereas it
becomes much less sensitive to Ca2+ inhibition at higher
[InsP3]i, enabling it to become activated. Thus,
InsP3 activates the channel by tuning the inhibition efficacy of the Ca2+ ligand. Of particular significance,
[Ca2+]i activation of the channel was
not modified by InsP3. However, it is unknown
whether other modulators of InsP3R activity similarly
impinge on the Ca2+ inhibition properties of the channel or
whether the Ca2+ activation properties of the channel are
exploited as an alternate method of channel regulation. The results
from the present study suggest that ATP stimulates gating of the
InsP3R by modulating the Ca2+ sensitivity of
the Ca2+ activation sites.
Regulation of InsP3-mediated Ca2+ Release
by ATP--
We performed a systematic investigation of the effects of
nucleotides on gating of the Xenopus type 1 InsP3R Ca2+ release channel. Our study focused
on the effects of ATP on single channel activity, and included
additional examination of effects of other nucleotides for comparison.
Stimulation of InsP3R by nucleotides in the presence of
InsP3 has been previously reported (20-23, 42, 43). The
majority of published studies measured the effects of nucleotides on
InsP3-induced Ca2+ fluxes either from
intracellular stores in permeabilized cells or into lipid vesicles
in vitro. ATP stimulation of InsP3-induced Ca2+ fluxes was reported in all these studies, but the
considerable qualitative as well as quantitative variability among them
makes comparison with our results difficult. Maximum stimulation by ATP
of Ca2+ release by the InsP3R has been reported
to range from 1.5- to 2-fold (20-22) the activity with
InsP3 alone. Considerable discrepancies exist regarding the
ATP concentration required for maximal stimulation, ranging from 10 µM (20) to 1 mM (21, 22). In terms of the nucleotide specificity, ADP was reported to be as potent as ATP (21,
22) or to be only 40% as effective (20) or ineffective (24); AMP has
been reported to stimulate to ~70% (21, 22) or 10% (20) of the ATP
stimulation level; GTP was ineffective (21) or stimulated to 30% of
the ATP stimulation level (22). Regarding the specific ATP species,
MgATP complex was as effective as free ATP (20) or only 50% as
effective (21).
Some reports indicate that the effects of ATP on InsP3R
activity are biphasic, being stimulatory at low [ATP]i and inhibitory at high [ATP]i (20-23). The concentrations at
which increased [ATP]i starts to reduce InsP3R
activity have varied from 0.1 (20) to 1 mM (21, 22) in
Ca2+ flux experiments. In bilayer experiments, ATP
concentrations of >5 mM inhibited channel activity with a
half-maximal concentration of 11 mM (23). In contrast,
recent Ca2+ flux studies found no inhibitory effects of ATP
at 5 (24) or 10 mM (42) on InsP3-induced
Ca2+ release from the ER. The results from our nuclear
patch clamp experiments are in agreement with these latter studies. We
detected no inhibitory effects of cytoplasmic ATP up to 10 mM. It has been suggested that the inhibitory effects of
high [ATP]i are caused by competitive inhibition of
InsP3 binding to the InsP3R (23). Therefore,
the different observations may be caused by different
[InsP3]i used in these studies, <5
µM in studies reporting ATP inhibition (20-23) and >5
µM in studies reporting no ATP inhibition (Refs. 24 and
42 and this study).
Stimulation of Single Channel Gating of the InsP3R by
ATP--
Many of the discrepancies in the results of Ca2+
flux studies may have been caused by species differences, different
concentrations of InsP3, or other important parameters,
including Ca2+ and other divalent cations (i.e.
Mg2+) whose concentrations in the vicinity of the
InsP3R might not have been adequately controlled.
Furthermore, the measurements of Ca2+ fluxes involved
populations of unknown numbers and multiple types of
InsP3R, which may also have contributed to the discrepant
results (42). Importantly, the effects of nucleotides on the activity of the InsP3R on the single molecule level can only be
inferred from these studies. There has been only one previous detailed investigation of the effects of ATP on single channel activity of the
InsP3R (23). In the presence of 0.2 µM
[Ca2+]i and 2 µM InsP3,
ATP enhanced the Po of canine cerebellum type 1 InsP3R reconstituted from microsomes into artificial planar lipid bilayers with a binding coefficient of 40 µM and
Hill coefficient of 1. The MgATP complex was as effective as free ATP,
whereas GTP was only 20% as effective and AMP was ineffective.
The effects of nucleotides on the Xenopus type 1 channel
observed by nuclear patch clamp in the present study have some
similarities but also differ in several important respects. In
agreement with the results from the bilayer study, the Hill coefficient
for ATP activation was also 1 in our study, although the apparent
binding coefficient KATP for free ATP was ~300
µM in our study, compared with 40 µM in the
bilayer study. In both studies, ATP activation of channel gating was
associated with stabilization of the open state and destabilization of
the closed state. Both studies concluded that ATP hydrolysis was not
involved, since nonhydrolyzable analogs were as effective as ATP in the
bilayer study. In contrast to the lipid bilayer results, the MgATP
complex had no stimulatory effects in our study; furthermore, free GTP
and AMP had potent stimulatory effects (both about 60% of the ATP
stimulation level) in the present study. The difference in nucleotide
specificity observed in the two studies is difficult to reconcile. It
may be caused by the different sources (canine versus
Xenopus), lipid environment (artificial lipid bilayers
versus native ER), and/or the isolation/reconstitution
protocols. Of particular interest is our finding that MgATP was without
effect on the channel activity. This distinction is important; whereas
the MgATP concentration in the cytoplasm is in the range of 3-8
mM (44-48), the cytoplasmic free ATP concentration is in
the range of 400-600 µM. The apparent affinity of 40 µM for ATP stimulation of the InsP3R in
bilayers and the apparent effectiveness of MgATP substituting for ATP
in InsP3R stimulation would suggest that ATP (free or
complexed with Mg2+) plays no role in channel modulation
under most conditions, since the total concentration of free and
magnesium-complexed ATP always far exceeds its apparent affinity for
the channel. In contrast, and as discussed in more detail below, our
determination that only free ATP is effective, with an apparent
affinity (apparent KD ~ 270 µM) that
is nearly coincident with levels in the cytoplasm, suggests that
physiological modulation of ATP levels in cells will have profound
effects on Ca2+ release activity of the InsP3R
by modifying its CICR properties. Of note, a recent study using
permeabilized lymphocytes that were engineered to express only the type
1 InsP3R found that free ATP enhanced
InsP3-induced Ca2+ release with an apparent
KD of 390 µM (42), in quite good
agreement with our channel results.
A second important distinction between our results and those of the
bilayer study concerns the mechanism by which ATP stimulates channel
gating. Our results demonstrate that ATP binding to the InsP3R increases the Ca2+ sensitivity of the
Ca2+ activation site of the channel. The bilayer
experiments were carried out at a single [Ca2+]i
(0.2 µM). The Po observed in 2 µM InsP3 increased from ~0.01 in the
absence of ATP to ~0.07 in 1 mM ATP (the order of
magnitude difference in absolute values of Po
observed in the two studies may be due to an InsP3
insensitivity of the reconstituted channels in the bilayer study (8)).
It was concluded that ATP binding to InsP3R increases the
intrinsic efficacy of InsP3 to activate the
InsP3R (23). However, our results demonstrate that ATP does
not affect Pmax. The increased
Po observed in the bilayer study can be
accounted for by the increase in affinity of the Ca2+
activation site observed in the present study (Fig. 5).
Regulation of the [Ca2+]i Dependence of
InsP3R Gating by ATP--
The present study represents the
first systematic investigation of the effects of ATP on single channel
activity of the InsP3R over a wide range of
[Ca2+]i (10 nM to 20 µM). Our results reveal the major mechanism by which
elevations of cytoplasmic free ATP stimulate gating of the
InsP3R, by demonstrating that ATP increases the affinity of the Ca2+ activating site of the channel specifically. ATP
decreased the half-maximal activating [Ca2+]i
(Kact), without affecting the maximum
Po. Although channel Po
decreased at low [ATP]i, this could be fully reversed by
increased [Ca2+]i. Therefore, ATP is not a
necessary agonist for activation of the InsP3R, but rather
it is an allosteric regulator, tuning the efficacy of
[Ca2+]i to stimulate the activity of the
InsP3-liganded InsP3R over a limited range of
[Ca2+]i (10 nM to 1 µM
as shown in Fig. 5). We previously showed that InsP3
activates the InsP3R solely by tuning the half-maximal inhibitory [Ca2+]i (Kinh)
of the channel, whereas activation of the InsP3R by
[Ca2+]i is unaffected (8). InsP3 is
therefore a regulator of Ca2+-inhibition of
Ca2+ release, whereas ATP is a regulator of CICR. Thus, the
effect of free ATP on the activation of the InsP3R by
[Ca2+]i complements the effect of
InsP3. Together, [ATP]i and
[InsP3]i each act as allosteric regulators to
tune the activation and inhibition, respectively, of the
InsP3R by [Ca2+]i.
It is not yet possible to completely describe the gating of the channel
under all conditions of [Ca2+]i,
[InsP3]i, and [ATP]i, because we have
yet to fully characterize the effects of ATP on Ca2+
inhibition of the channel under submaximal [InsP3]. The
data we obtained under saturating [InsP3] suggest the
possibility that ATP also affects the Ca2+ inhibition phase
of the [Ca2+]i dependence curve by making the
channel less sensitive to [Ca2+]i inhibition.
This mode of regulation is therefore analogous to that of
InsP3. Further studies are required to define the effects of free ATP on Ca2+ inhibition of the channel and the
relationship of those effects to that of InsP3.
Nevertheless, it is interesting to consider the similarities involved
in the regulation of channel gating by ATP and InsP3. As
mentioned earlier, InsP3 is a channel activator because it
decreases the affinity of the Ca2+ inhibition site of the
channel. It is important to note, however, that it is not the absolute
magnitude of the Ca2+ affinity of that site that is
critical for InsP3R activity, but rather its relationship
to that of the Ca2+ activation site. The higher
Ca2+ affinity of the inhibition site keeps the channel
inactive in the absence of InsP3. However, the
Ca2+ affinity of the inhibition site becomes less than that
of the activation site when the channel binds InsP3. It
follows, therefore, that an alternate mechanism to activate the channel
would be to increase the Ca2+ affinity of the activation
site. Because this is a major effect of ATP, we speculate that suitable
conditions could be defined in which channel gating could be activated
by an increase in [ATP]i without any change in
[InsP3]i. Because the relative affinities for
Ca2+ of the InsP3R activation and inhibition
sites is the critical factor in determining the level of channel
activity, it follows that allosteric regulation of antagonistic
Ca2+-binding sites by ATP and InsP3, by
together tuning the Ca2+ dependence of channel gating,
render the Ca2+ dependence of Ca2+ release by
the InsP3R a dynamic property, dependent upon stimulus intensity and cell metabolic state.
Physiological Implications--
The results of our study suggest
that complex features of InsP3-induced
[Ca2+]i signals will be dependent upon an
elaborate regulation of Ca2+ release through the
InsP3R by [Ca2+]i,
[InsP3]i, and [ATP]i. Importantly, modulation of channel activity by both ATP and InsP3 is
achieved by regulating the [Ca2+]i dependence of
channel gating. The interplay between [ATP]i and
[Ca2+]i in the control of InsP3R
channel activities observed in the present study probably has important
physiological significance, particularly if the InsP3R
actually experiences various [ATP]i. Our results indicate
that the apparent affinity of the ATP-binding site on the
InsP3R is physiologically relevant, since it approximates the free ATP concentration in the cytoplasm. Estimates of total Mg2+ (44, 45) and total ATP (46-48) concentrations in
cells are each in the range of 5-10 mM. Assuming equal
concentrations of each, the free ATP concentration is calculated to
vary roughly from 420 µM (5 mM total
Mg2+) to 540 µM (8 mM total
Mg2+). For comparison, the apparent affinity of the
ATP-binding site on the InsP3R was determined in the
present study to be 270 µM. Interestingly, not only is
the apparent affinity of the ATP-binding site on the InsP3R
coincident with the normal cytoplasmic free ATP concentration, but
changes in free ATP concentration are very sensitive to changes in
total ATP concentration in the cytoplasm. For example, at 5 mM total Mg2+, an increase of total ATP
concentration from 5 to 5.5 mM (10% change) will result in
a 1.5-fold increase in the concentration of free ATP (from ~420
µM to ~600 µM). Thus, relatively small changes in total cytoplasmic ATP can have pronounced effects on free
ATP concentration and, therefore, on the CICR properties of the
InsP3R. Thus, our results suggest that the channel is
poised in vivo to respond to changes in the free ATP
concentration, for example those that may occur during ischemia.
Therefore, the nucleotide sensitivity may enable Ca2+
release properties of the InsP3R to be tuned to the
metabolic state of the cell.
It has become evident from several recent studies that mitochondria and
the ER form a tightly coupled, complex signaling unit. Imaging studies
have revealed that mitochondria are in close physical proximity to the
ER (25), especially to sites of Ca2+ release (26). In
cerebellar Purkinje cells, ER cisternae containing high densities of
InsP3R-1 are often wrapped around or closely apposed to
mitochondria (49, 50). A physiological implication of this structural
arrangement is that it enables the rise in [Ca2+]i caused by agonist-stimulated
InsP3R activity to be effectively transmitted as a
transient increase in mitochondrial matrix [Ca2+] that
closely parallels the [Ca2+]i rise, due to the
locally high [Ca2+]i in the microdomain of the
release channels and rapid uptake of released Ca2+ by the
mitochondria (28-30, 33, 51). The resulting changes in mitochondrial
matrix [Ca2+] affect the mitochondrial membrane potential
(32) and the activities of the mitochondrial dehydrogenases that are
crucial in ATP synthesis and intracellular ATP levels (27, 31, 33, 34,
52). The cytosolic ATP concentration in turn affects processes that
contribute to [Ca2+]i regulation, including
InsP3-induced Ca2+ release (Refs. 20-24 and 43
and this study), passive leak from Ca2+ stores (53), plasma
membrane store-operated Ca2+ entry (24, 54, 55), and
Ca2+ extrusion and uptake into the ER by
Ca2+-ATPases (24, 56, 57). Thus, in addition to buffering
[Ca2+]i directly by active Ca2+
sequestration and export (58-62), mitochondria indirectly participate in intracellular Ca2+ signaling, using cytosolic ATP as a
global cytoplasmic messenger. We speculate that the close physical
proximity of mitochondria and ER may enable local changes in
ATP concentration, due to release from mitochondria into the
microdomains of close ER-mitochondria apposition, to rapidly effect
local InsP3R-mediated Ca2+ release. Of
significance, the ATP released by mitochondria is free ATP, the
InsP3R ligand, not MgATP (63). Thus, communication between
these two organelles may be two-way, with local Ca2+
release as the currency of communication from ER to mitochondria and
local ATP release providing the cross-talk from mitochondria to ER.
The phosphoinositide signaling system is highly expressed throughout
the brain (64, 65). Recent observations suggest that Ca2+
release from type 1 InsP3 receptors is involved in nerve
growth (66) and synaptic plasticity, including long term potentiation (67-69) and depression (LTD) (67, 67, 70-72). Disruption of the mouse
InsP3R-1 gene eliminates LTD in the cerebellum (70), and
the competitive InsP3R inhibitor heparin blocks LTD in the neocortex (73). Metabotropic glutamate receptors (mGluR), which couple
to the InsP3 signaling pathway, have been implicated in synaptic plasticity (65, 69, 73), and mice with targeted disruption of
mGluR1 show impaired LTD (74, 75). InsP3-mediated LTD in
Purkinje cell dendrites was recently shown to be spatially restricted
to sites where both mGluR and InsP3R are located (71). Ca2+ influx through
N-methyl-D-aspartate receptors and voltage-gated channels is considered to be of major importance in synaptic plasticity (65). Synaptic plasticity in several different brain regions requires
both Ca2+ entry and mGluR/InsP3R (72, 76, 77),
and it been suggested that Ca2+ influx might serve to
trigger Ca2+ release by CICR (65, 69, 78), with
InsP3Rs therefore playing a critical role in amplifying the
Ca2+ influx signal (65). Importantly,
[Ca2+]i signaling in nonexcitable cells is also
associated with both Ca2+ release from stores and
Ca2+ influx, and Ca2+ influx has been
demonstrated to play a similar role in amplifying and modifying
InsP3-mediated [Ca2+]i signals (79).
By demonstrating that the Ca2+ sensitivity of CICR by the
InsP3R-1 can be regulated, our data raise the possibility
that synaptic plasticity and other cellular processes involving
InsP3Rs may be modulated by physiological stimuli that
impinge on the Ca2+ sensitivity of the release channel. The
results of the present study suggest that cytoplasmic ATP, and
therefore the metabolic status of the cell, may be relevant in this
respect. Of note, phospholipase C activity in brain tissue is enhanced
in response to ischemia (80), and exposure of hippocampal slices to
anoxia (81) or 2-deoxyglucose (13), manipulations expected to alter cytoplasmic ATP concentrations, induce long term potentiation. Directed
studies of the role of cell metabolic state and cytoplasmic ATP
concentrations in controlling InsP3-mediated
Ca2+ release will be required to determine the relevance of
ATP regulation of InsP3R gating for synaptic plasticity as
well as other cellular processes.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence and reprint requests should be
addressed: Dept. of Physiology, University of Pennsylvania, B39
ANAT-CHEM, Philadelphia, PA 19104-6085. Tel.: 215-898-1354; Fax:
215-573-6808; E-mail: foskett@mail.med.upenn.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
InsP3, inositol 1,4,5-trisphosphate;
InsP3R, InsP3
receptor;
ER, endoplasmic reticulum;
BAPTA, 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
LTD, long term depression;
mGluR, metabotropic glutamate receptor(s).
 |
REFERENCES |
| 1.
|
Taylor, C. W.,
and Richardson, A.
(1991)
Pharmacol. Ther.
51,
97-137[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Berridge, M. J.
(1993)
Nature
361,
315-325[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Putney, J. W., Jr.,
St, J.,
and Bird, G.
(1993)
Endocr. Rev.
14,
610-631[Abstract/Free Full Text]
|
| 4.
|
Carter, T. D.,
and Ogden, D.
(1997)
J. Physiol. (Lond.)
504,
17-33[Abstract/Free Full Text]
|
| 5.
|
Meyer, T.,
Holowka, D.,
and Stryer, L.
(1988)
Science
240,
653-655[Abstract/Free Full Text]
|
| 6.
|
Finch, E. A.,
Turner, T. J.,
and Goldin, S. M.
(1991)
Science
252,
443-446[Abstract/Free Full Text]
|
| 7.
|
Dufour, J.-F.,
Arias, I. M.,
and Turner, T. J.
(1997)
J. Biol. Chem.
272,
2675-2681[Abstract/Free Full Text]
|
| 8.
|
Mak, D.-O. D.,
McBride, S.,
and Foskett, J. K.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15821-15825[Abstract/Free Full Text]
|
| 9.
|
Iino, M.
(1990)
J. Gen. Physiol.
95,
1103-1122[Abstract/Free Full Text]
|
| 10.
|
Marshall, I. C. B.,
and Taylor, C. W.
(1993)
J. Biol. Chem.
268,
13214-13220[Abstract/Free Full Text]
|
| 11.
|
Bezprozvanny, I.,
Watras, J.,
and Ehrlich, B. E.
(1991)
Nature
351,
751-754[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Meyer, T.,
and Stryer, L.
(1991)
Annu. Rev. Biophys. Biophys. Chem.
20,
153-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Tekkok, S.,
and Krnjevic, K.
(1996)
J. Neurophysiol.
76,
2343-2352[Abstract/Free Full Text]
|
| 14.
|
Toescu, E. C.
(1995)
Am. J. Physiol.
269,
G173-G185[Abstract/Free Full Text]
|
| 15.
|
Bootman, M. D.
(1994)
Mol. Cell. Endocrinol.
98,
157-166[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Mignery, G. A.,
Sudhof, T. C.,
Takei, K.,
and De Camilli, P.
(1989)
Nature
342,
192-195[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Mikoshiba, K.
(1993)
Trends Pharmacol. Sci.
14,
86-89[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Taylor, C. W.,
and Traynor, D.
(1995)
J. Membr. Biol.
145,
109-118[Medline]
[Order article via Infotrieve]
|
| 19.
|
Maeda, N.,
Kawasaki, T.,
Nakade, S.,
Yokota, N.,
Taguchi, T.,
Kasai, M.,
and Mikoshiba, K.
(1991)
J. Biol. Chem.
266,
1109-1116[Abstract/Free Full Text]
|
| 20.
|
Ferris, C. D.,
Huganir, R. L.,
and Snyder, S. H.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2147-2151[Abstract/Free Full Text]
|
| 21.
|
Iino, M.
(1991)
J. Gen. Physiol.
98,
681-698[Abstract/Free Full Text]
|
| 22.
|
Missiaen, L.,
Parys, J. B.,
De Smedt, H.,
Sienaert, I.,
Sipma, H.,
Vanlingen, S.,
Maes, K.,
and Casteels, R.
(1997)
Biochem. J.
325,
661-666
|
| 23.
|
Bezprozvanny, I.,
and Ehrlich, B. E.
(1993)
Neuron
10,
1175-1184[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Landolfi, B.,
Curci, S.,
Debellis, L.,
Pozzan, T.,
and Hofer, A. M.
(1998)
J. Cell Biol.
142,
1235-1243[Abstract/Free Full Text]
|
| 25.
|
Rizzuto, R.,
Pinton, P.,
Carrington, W.,
Fay, F. S.,
Fogarty, K. E.,
Lifshitz, L. M.,
Tuft, R. A.,
and Pozzan, T.
(1998)
Science
280,
1763-1766[Abstract/Free Full Text]
|
| 26.
|
Simpson, P. B.,
Mehotra, S.,
Lange, G. D.,
and Russell, J. T.
(1997)
J. Biol. Chem.
272,
22654-22661[Abstract/Free Full Text]
|
| 27.
|
Robb-Gaspers, L. D.,
Rutter, G. A.,
Burnett, P.,
Hajnóczky, G.,
Denton, R. M.,
and Thomas, A. P.
(1998)
Biochim. Biophys. Acta
1366,
17-32[Medline]
[Order article via Infotrieve]
|
| 28.
|
Rizzuto, R.,
Brini, M.,
Murgia, M.,
and Pozzan, T.
(1993)
Science
262,
744-747[Abstract/Free Full Text]
|
| 29.
|
Rizzuto, R.,
Bastianutto, C.,
Brini, M.,
Murgia, M.,
and Pozzan, T.
(1994)
J. Cell Biol.
126,
1183-1194[Abstract/Free Full Text]
|
| 30.
|
Csordás, G.,
Thomas, A. P.,
and Hajnóczky, G.
(1999)
EMBO J.
18,
96-108[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
McCormack, J. G.,
and Denton, R. M.
(1993)
Dev. Neurosci.
15,
165-173[Medline]
[Order article via Infotrieve]
|
| 32.
|
Loew, L. M.,
Carrington, W.,
Tuft, R. A.,
and Fay, F. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12579-12583[Abstract/Free Full Text]
|
| 33.
|
Rutter, G. A.,
Burnett, P.,
Rizzuto, R.,
Brini, M.,
Murgia, M.,
Pozzan, T.,
Tavaré, J. M.,
and Denton, R. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5489-5494[Abstract/Free Full Text]
|
| 34.
|
Robb-Gaspers, L. D.,
Burnett, P.,
Rutter, G. A.,
Denton, R. M.,
Rizzuto, R.,
and Thomas, A. P.
(1998)
EMBO J.
17,
4987-5000[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Mak, D.-O. D.,
and Foskett, J. K.
(1994)
J. Biol. Chem.
269,
29375-29378[Abstract/Free Full Text]
|
| 36.
|
Mak, D.-O. D.,
and Foskett, J. K.
(1997)
J. Gen. Physiol.
109,
571-587[Abstract/Free Full Text]
|
| 37.
|
Stehno-Bittel, L.,
Lückhoff, A.,
and Clapham, D. E.
(1995)
Neuron
14,
163-167[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Furuichi, T.,
Yoshikawa, S.,
Miyawaki, A.,
Wada, K.,
Maeda, N.,
and Mikoshiba, K.
(1989)
Nature
342,
32-38[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Mignery, G. A.,
Newton, C. L.,
Archer, B. T., III,
and Sudhof, T. C.
(1990)
J. Biol. Chem.
265,
12679-12685[Abstract/Free Full Text]
|
| 40.
|
Mak, D.-O. D,
and Foskett, J. K.
(1998)
Am. J. Physiol.
275,
C179-C188
|
| 41.
|
Kume, S.,
Muto, A.,
Aruga, J.,
Nakagawa, T.,
Michikawa, T.,
Furuichi, T.,
Nakade, S.,
Okano, H.,
and Mikoshiba, K.
(1993)
Cell
73,
555-570[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Miyakawa, T.,
Maeda, A.,
Yamazawa, T.,
Hirose, K.,
Kurosake, T.,
and Iino, M.
(1999)
EMBO J.
18,
1303-1308[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Missiaen, L.,
Parys, J. B.,
Sienaert, I.,
Maes, K.,
Kunzelmann, K.,
Takahashi, M.,
Tanzawa, K.,
and De Smedt, H.
(1998)
J. Biol. Chem.
273,
8983-8986[Abstract/Free Full Text]
|
| 44.
|
Corkey, B. E.,
Duszynski, J.,
Rich, T. L.,
Matschinsky, B.,
and Williamson, J. R.
(1986)
J. Biol. Chem.
261,
2567-2574[Abstract/Free Full Text]
|
| 45.
|
Flatman, P. W.
(1991)
Annu. Rev. Physiol.
53,
259-271[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Dunne, M. J.,
West-Jordan, J. A.,
Abraham, R. J.,
Edwards, R. T. H.,
and Petersen, O. H.
(1988)
J. Membr. Biol.
104,
165-172[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Kargacin, M. E.,
and Kargacin, G. J.
(1997)
Am. J. Physiol.
273,
C1416-C1426
|
| 48.
|
Maechler, P.,
Wang, H. Y.,
and Wollheim, C. B.
(1998)
FEBS Lett.
422,
328-332[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Otsu, H.,
Yamamoto, A.,
Maeda, N.,
Mikoshiba, K.,
and Tashiro, Y.
(1990)
Cell Struct. Funct.
15,
163-173[Medline]
[Order article via Infotrieve]
|
| 50.
|
Satoh, T.,
Ross, C. A.,
Villa, A.,
Supattapone, S.,
Pozzan, T.,
Snyder, S. H.,
and Meldolesi, J.
(1990)
J. Cell Biol.
111,
615-624[Abstract/Free Full Text]
|
| 51.
|
Babcock, D. F.,
and Hille, B.
(1998)
Curr. Opin. Neurobiol.
8,
398-404[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Hajnóczky, G.,
Robb-Gaspers, L. D.,
Seitz, M. B.,
and Thomas, A. P.
(1995)
Cell
82,
415-424[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Hofer, A. M.,
Curci, S.,
Machen, T. E.,
and Schulz, I.
(1996)
FASEB J.
10,
302-308[Abstract]
|
| 54.
|
Gamberucci, A.,
Innocenti, B.,
Fulceri, R.,
Bànhegyi, G.,
Giunti, R.,
Pozzan, T.,
and Benedetti, A.
(1994)
J. Biol. Chem.
269,
23597-23602[Abstract/Free Full Text]
|
| 55.
|
Marriott, I.,
and Mason, M. J.
(1995)
Am. J. Physiol. Cell Physiol.
269,
C766-C774[Abstract/Free Full Text]
|
| 56.
|
Fasolato, C.,
Zottini, M.,
Clementi, E.,
Zacchetti, D.,
Meldolesi, J.,
and Pozzan, T.
(1991)
J. Biol. Chem.
266,
20159-20167[Abstract/Free Full Text]
|
| 57.
|
Al-Baldawi, N. F.,
Moore, J. E.,
and Abercrombie, R. F.
(1993)
J. Physiol. (Lond.)
461,
633-646[Abstract/Free Full Text]
|
| 58.
|
Martínez-Serrano, A.,
and Satrústegui, J.
(1992)
Mol. Biol. Cell
3,
235-248[Abstract]
|
| 59.
|
Jouaville, L. S.,
Ichas, F.,
Holmuhamedov, E. L.,
Camacho, P.,
and Lechleiter, J. D.
(1995)
Nature
377,
438-441[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Simpson, P. B.,
and Russell, J. T.
(1996)
J. Biol. Chem.
271,
33493-33501[Abstract/Free Full Text]
|
| 61.
|
Babcock, D. F.,
Herrington, J.,
Goodwin, P. C.,
Park, Y. B.,
and Hille, B.
(1997)
J. Cell Biol.
136,
833-844[Abstract/Free Full Text]
|
| 62.
|
Ichas, F.,
Jouaville, L. S.,
and Mazat, J. P.
(1997)
Cell
89,
1145-1153[CrossRef][Medline]
[Order article via Infotrieve]
|
| 63.
|
Klingenberg, M.
(1980)
J. Membr. Biol.
56,
97-105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 64.
|
Furuichi, T.,
and Mikoshiba, K.
(1995)
J. Neurochem.
64,
953-960[Medline]
[Order article via Infotrieve]
|
| 65.
|
Berridge, M. J.
(1998)
Neuron
21,
13-26[CrossRef][Medline]
[Order article via Infotrieve]
|
| 66.
|
Takei, K.,
Shin, R.-M.,
Inoue, T.,
Kato, K.,
and Mikoshiba, K.
(1998)
Science
282,
1705-1708[Abstract/Free Full Text]
|
| 67.
|
Khodakhah, K.,
and Armstrong, C. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14009-14014[Abstract/Free Full Text]
|
| 68.
|
Komatsu, Y.
(1996)
J. Neurosci.
16,
6342-6352[Abstract/Free Full Text]
|
| 69.
|
Kasai, H.,
and Petersen, O. H.
(1994)
Trends Neurosci.
17,
95-101[CrossRef][Medline]
[Order article via Infotrieve]
|
| 70.
|
Inoue, T.,
Kato, K.,
Kohda, K.,
and Mikoshiba, K.
(1998)
J. Neurosci.
18,
5366-5373[Abstract/Free Full Text]
|
| 71.
|
Finch, E. A.,
and Augustine, G. J.
(1998)
Nature
396,
753-756[CrossRef][Medline]
[Order article via Infotrieve]
|
| 72.
|
Linden, D. J.,
and Connor, J. A.
(1995)
Annu. Rev. Neurosci.
18,
319-357[CrossRef][Medline]
[Order article via Infotrieve]
|
| 73.
|
Kato, N.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3650-3654[Abstract/Free Full Text]
|
| 74.
|
Conquet, F.,
Bashir, Z. I.,
Davies, C. H.,
Daniel, H.,
Ferraguti, F.,
Bordi, F.,
Franz-Bacon, K.,
Reggiani, A.,
Matarese, V.,
Conde, F.,
Collingridge, G. L.,
and Crepel, F.
(1994)
Nature
372,
237-243[CrossRef][Medline]
[Order article via Infotrieve]
|
| 75.
|
Aiba, A.,
Kano, M.,
Chen, M. C.,
Stanton, M. E.,
Fox, G. D.,
Herrup, K.,
Zwingman, T. A.,
and Tonegawa, S.
(1994)
Cell
79,
377-388[CrossRef][Medline]
[Order article via Infotrieve]
|
| 76.
|
Ito, M.
(1989)
Annu. Rev. Neurosci.
12,
85-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 77.
|
Otani, S.,
and Connor, J. A.
(1998)
J. Physiol.
511,
761-770[Abstract/Free Full Text]
|
| 78.
|
Llano, I.,
DiPolo, R.,
and Marty, A.
(1994)
Neuron
12,
663-673[CrossRef][Medline]
[Order article via Infotrieve]
|
| 79.
|
Girard, S. E.,
and Clapham, D. E.
(1993)
Science
260,
229-232[Abstract/Free Full Text]
|
| 80.
|
Nagata, E.,
Tanaka, K.,
Gomi, S.,
Mihara, B.,
Shirai, T.,
Nogawa, S.,
Nozaki, H.,
Mikoshiba, K.,
and Fukuuchi, Y.
(1994)
Neuroscience
61,
983-990[CrossRef][Medline]
[Order article via Infotrieve]
|
| 81.
|
Hsu, K. S.,
and Huang, C. C.
(1997)
Br. J. Pharmacol.
122,
671-681[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Betzenhauser, L. E. Wagner II, H. S. Park, and D. I. Yule
ATP Regulation of Type-1 Inositol 1,4,5-Trisphosphate Receptor Activity Does Not Require Walker A-type ATP-binding Motifs
J. Biol. Chem.,
June 12, 2009;
284(24):
16156 - 16163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Nagaleekar, S. A. Diehl, I. Juncadella, C. Charland, N. Muthusamy, S. Eaton, L. Haynes, L. A. Garrett-Sinha, J. Anguita, and M. Rincon
IP3 Receptor-Mediated Ca2+ Release in Naive CD4 T Cells Dictates Their Cytokine Program
J. Immunol.,
December 15, 2008;
181(12):
8315 - 8322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Park, M. J. Betzenhauser, J. H. Won, J. Chen, and D. I. Yule
The Type 2 Inositol (1,4,5)-Trisphosphate (InsP3) Receptor Determines the Sensitivity of InsP3-induced Ca2+ Release to ATP in Pancreatic Acinar Cells
J. Biol. Chem.,
September 19, 2008;
283(38):
26081 - 26088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Betzenhauser, L. E. Wagner II, M. Iwai, T. Michikawa, K. Mikoshiba, and D. I. Yule
ATP Modulation of Ca2+ Release by Type-2 and Type-3 Inositol (1, 4, 5)-Triphosphate Receptors: DIFFERING ATP SENSITIVITIES AND MOLECULAR DETERMINANTS OF ACTION
J. Biol. Chem.,
August 1, 2008;
283(31):
21579 - 21587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Wagner II, S. K. Joseph, and D. I. Yule
Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation
J. Physiol.,
August 1, 2008;
586(15):
3577 - 3596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Power and P. Sah
Competition between Calcium-Activated K+ Channels Determines Cholinergic Action on Firing Properties of Basolateral Amygdala Projection Neurons
J. Neurosci.,
March 19, 2008;
28(12):
3209 - 3220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev,
April 1, 2007;
87(2):
593 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. White, J. Yang, M. J. Monteiro, and J. K. Foskett
CIB1, a Ubiquitously Expressed Ca2+-binding Protein Ligand of the InsP3 Receptor Ca2+ Release Channel
J. Biol. Chem.,
July 28, 2006;
281(30):
20825 - 20833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Wagner II, M. J. Betzenhauser, and D. I. Yule
ATP Binding to a Unique Site in the Type-1 S2- Inositol 1,4,5-Trisphosphate Receptor Defines Susceptibility to Phosphorylation by Protein Kinase A
J. Biol. Chem.,
June 23, 2006;
281(25):
17410 - 17419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-X. Yi and I. M. Bird
Pregnancy-Specific Modulatory Role of Mitochondria on Adenosine 5'-Triphosphate-Induced Cytosolic [Ca2+] Signaling in Uterine Artery Endothelial Cells
Endocrinology,
November 1, 2005;
146(11):
4844 - 4850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dumollard, P. Marangos, G. Fitzharris, K. Swann, M. Duchen, and J. Carroll
Sperm-triggered [Ca2+] oscillations and Ca2+ homeostasis in the mouse egg have an absolute requirement for mitochondrial ATP production
Development,
July 1, 2004;
131(13):
3057 - 3067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-O. D. Mak, S. M.J. McBride, and J. K. Foskett
Spontaneous Channel Activity of the Inositol 1,4,5-Trisphosphate (InsP3) Receptor (InsP3R). Application of Allosteric Modeling to Calcium and InsP3 Regulation of InsP3R Single-channel Gating
J. Gen. Physiol.,
October 27, 2003;
122(5):
583 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dumollard, K. Hammar, M. Porterfield, P. J. Smith, C. Cibert, C. Rouviere, and C. Sardet
Mitochondrial respiration and Ca2+ waves are linked during fertilization and meiosis completion
Development,
February 15, 2003;
130(4):
683 - 692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Lenz, H. P. Reusch, N. Albrecht, G. Schultz, and M. Schaefer
Ca2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells
J. Cell Biol.,
October 28, 2002;
159(2):
291 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dumollard, J. Carroll, G. Dupont, and C. Sardet
Calcium wave pacemakers in eggs
J. Cell Sci.,
September 15, 2002;
115(18):
3557 - 3564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Yoo, Y. S. Oh, M. K. Kang, Y. H. Huh, S. H. So, H. S. Park, and H. Y. Park
Localization of Three Types of the Inositol 1,4,5-Trisphosphate Receptor/Ca2+ Channel in the Secretory Granules and Coupling with the Ca2+ Storage Proteins Chromogranins A and B
J. Biol. Chem.,
November 30, 2001;
276(49):
45806 - 45812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Missiaen, H. DeSmedt, G. Bultynck, S. Vanlingen, P. Desmet, G. Callewaert, and J. B. Parys
Calmodulin Increases the Sensitivity of Type 3 Inositol-1,4,5-trisphosphate Receptors to Ca2+ Inhibition in Human Bronchial Mucosal Cells
Mol. Pharmacol.,
March 1, 2000;
57(3):
564 - 567.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Boehning and S. K. Joseph
Functional Properties of Recombinant Type I and Type III Inositol 1,4,5-Trisphosphate Receptor Isoforms Expressed in COS-7 Cells
J. Biol. Chem.,
July 7, 2000;
275(28):
21492 - 21499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Marchant, V. Ramos, and I. Parker
Structural and functional relationships between Ca2+ puffs and mitochondria in Xenopus oocytes
Am J Physiol Cell Physiol,
June 1, 2002;
282(6):
C1374 - C1386.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|